BRCA2 and cancer: Defective homologous recombination (HR)-mediated DNA repair as a result of mutations in BRCA1/BRCA2 genes is related to genomic instability and generates a unique sensitivity in cancer cells to DNA-targeting agents, which induce irreversible DNA damages.